1. Home
  2. CATO vs FORA Comparison

CATO vs FORA Comparison

Compare CATO & FORA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cato Corporation (The)

CATO

Cato Corporation (The)

N/A

Current Price

$3.12

Market Cap

61.6M

ML Signal

N/A

Logo Forian Inc.

FORA

Forian Inc.

N/A

Current Price

$2.09

Market Cap

66.2M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
CATO
FORA
Founded
1946
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Clothing/Shoe/Accessory Stores
Computer Software: Prepackaged Software
Sector
Consumer Discretionary
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
61.6M
66.2M
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
CATO
FORA
Price
$3.12
$2.09
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
51.0K
16.6K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
17.09
N/A
EPS
0.25
N/A
Revenue
$649,806,000.00
$20,153,263.00
Revenue This Year
N/A
$51.82
Revenue Next Year
N/A
$7.24
P/E Ratio
$12.36
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.19
$1.64
52 Week High
$4.92
$2.71

Technical Indicators

Market Signals
Indicator
CATO
FORA
Relative Strength Index (RSI) 50.17 46.06
Support Level $2.80 $2.05
Resistance Level $3.22 $2.12
Average True Range (ATR) 0.18 0.02
MACD 0.02 0.00
Stochastic Oscillator 40.38 40.00

Price Performance

Historical Comparison
CATO
FORA

About CATO Cato Corporation (The)

The Cato Corp operates as a specialty retailer of fashion apparel and accessories in the southeastern United States. Its primary objective is to be the fashion specialty retailer for fashion and value in its markets. The company operates through the following business segments: Retail and Credit. The Retail segment which generates the majority of revenue offers fashion specialty stores. The Credit segment involves credit card services.

About FORA Forian Inc.

Forian Inc provides a suite of Software, data management capabilities, and proprietary data and analytics to optimize and measure operational, clinical, and financial performance for customers within the traditional and emerging life sciences, healthcare payer, and provider segments, as well as cannabis dispensaries, manufacturers, and cultivators.

Share on Social Networks: